Home > Healthcare > Pharmaceuticals > Finished Drug Form > Triptorelin Market

Triptorelin Market Analysis

  • Report ID: GMI5427
  • Published Date: Feb 2023
  • Report Format: PDF

Triptorelin Market Analysis

Global Triptorelin Market Share, By Drug Type

To understand key trends  
Download Free Sample
 

Based on drug, triptorelin market share from triptorelin embonate segment is anticipated to grow at over 5% CAGR from 2023 to 2032, driven primarily by the growing number of prostate cancer cases worldwide. According to Global Cancer Observatory, GLOBOCAN, over 1.4 million prostate cancer cases were reported worldwide in 2020. Triptorelin embonate sees high demand owing to its efficacy in the treatment of advanced prostate cancer.
 

The intramuscular administration of 22.5 grams of triptorelin embonate in a 6-month formulation among men with advanced prostate cancer has been shown to initially increase their serum testosterone levels. It is also generally well-tolerated in such patients and has only mild severity of adverse reactions.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for triptorelin held a valuation of over USD 910 million in 2022 and is projected to grow at over 5% CAGR from 2023 to 2032, on account of surging occurrence of endometriosis across the global female population.

The triptorelin market size from the intradermal segment is anticipated to grow at over 4.5% CAGR from 2023 to 2032, fueled by the growing number of hormone therapies performed annually across the globe.

Europe triptorelin business valuation is poised to surpass USD 370 million by 2032, owing to the growing prevalence of diseases such as cancer and endometriosis in the region, coupled with increasing government investments towards the health and well-being of its citizens.

Some of the major triptorelin industry contenders include Taj Pharmaceuticals Limited., Anhui Anke Bioengineering (Group) Co., Ltd., Biozenta Lifescience Pvt. Ltd, Azurity Pharmaceuticals, Inc., and Verity Pharmaceuticals Inc., among others.

Triptorelin Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 373
  • Countries covered: 32
  • Pages: 320
 Download Free Sample